Jefferies Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $25

Jefferies analyst Faisal Khurshid has initiated coverage on Vicore Pharma Holding (NASDAQ: VCRE) with a Buy rating. The firm has set a price target of $25 for the company's stock.